SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Genpact Limited (G) trades at a trailing P/E of 11.1, forward P/E of 8.8. Trailing earnings yield is 8.99%, forward earnings yield 11.31%. PEG 1.14. Graham Number is $32.76.
Criteria proven by this page:
- VALUE (69/100, Pass) — P/E is below market average (11.1); analyst target implies upside (+29.6%); earnings yield beats bond yields (8.99%).
- Forward P/E 8.8 (down from trailing 11.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.14 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 8.99% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 11.31% as earnings recover.
- Analyst consensus target $46.00 (+29.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 70/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
69/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — G
Valuation Multiples
P/E (TTM)11.1
Forward P/E8.8
PEG Ratio1.14
Forward PEG0.31
P/B Ratio2.41
P/S Ratio1.20
EV/EBITDA8.1
Per Share Data
EPS (TTM)$3.21
Forward EPS (Est.)$4.02
Book Value / Share$14.83
Revenue / Share$29.56
FCF / Share$4.26
Yields & Fair Value
Earnings Yield8.99%
Forward Earnings Yield11.31%
Dividend Yield1.95%
Graham Number$32.76
SharesGrow IV$177.39 (+399.7%)
Analyst Target$46.00 (+29.6%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
18.8 |
1.10 |
3.91 |
1.96 |
- |
| 2017 |
23.6 |
5.11 |
4.32 |
2.25 |
0.76% |
| 2018 |
18.3 |
2.07 |
3.66 |
1.71 |
1.11% |
| 2019 |
26.3 |
3.24 |
4.75 |
2.28 |
0.81% |
| 2020 |
25.5 |
20.44 |
4.29 |
2.12 |
0.94% |
| 2021 |
27.0 |
1.25 |
5.25 |
2.48 |
0.81% |
| 2022 |
24.1 |
-9.51 |
4.67 |
1.95 |
1.08% |
| 2023 |
10.0 |
0.13 |
2.81 |
1.41 |
1.58% |
| 2024 |
14.9 |
-0.89 |
3.21 |
1.61 |
1.42% |
| 2025 |
14.7 |
1.41 |
3.19 |
1.60 |
1.45% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.28 |
$2.57B |
$267.55M |
10.4% |
| 2017 |
$1.34 |
$2.74B |
$260.84M |
9.5% |
| 2018 |
$1.45 |
$3B |
$281.26M |
9.4% |
| 2019 |
$1.56 |
$3.52B |
$304.88M |
8.7% |
| 2020 |
$1.57 |
$3.71B |
$308.28M |
8.3% |
| 2021 |
$1.91 |
$4.02B |
$369.45M |
9.2% |
| 2022 |
$1.88 |
$4.37B |
$353.4M |
8.1% |
| 2023 |
$3.41 |
$4.48B |
$631.26M |
14.1% |
| 2024 |
$2.85 |
$4.77B |
$513.67M |
10.8% |
| 2025 |
$3.13 |
$5.08B |
$552.49M |
10.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$4.02 |
$3.99 – $4.04 |
$5.44B |
$5.43B – $5.45B |
9 |
| 2027 |
$4.44 |
$4.35 – $4.51 |
$5.83B |
$5.78B – $5.86B |
9 |
| 2028 |
$5.05 |
$4.88 – $5.20 |
$6.33B |
$6.33B – $6.33B |
3 |
